Stage-Dependent Effects of Rapamycin for Alzheimer’s Disease: Insights from Prevention and Treatment Trials

Abstract

Rapamycin is the best-established longevity-promoting drug in animal models and has been shown to attenuate Alzheimer’s disease pathology in preclinical trials.